ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 177 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,660 | +65.1% | 25,932 | +216.2% | 0.00% | 0.0% |
| Q2 2023 | $175,480 | -63.7% | 8,200 | -31.5% | 0.00% | 0.0% |
| Q1 2023 | $483,986 | -64.3% | 11,968 | -58.3% | 0.00% | -83.3% |
| Q2 2022 | $1,357,000 | +3891.2% | 28,700 | +7075.0% | 0.01% | – |
| Q2 2019 | $34,000 | -95.3% | 400 | -95.2% | 0.00% | -100.0% |
| Q3 2018 | $718,000 | -58.5% | 8,400 | -85.1% | 0.00% | -70.0% |
| Q1 2017 | $1,731,000 | – | 56,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
| Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
| ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
| Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
| Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
| Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
| AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
| Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |